0001127602-24-013820.txt : 20240502 0001127602-24-013820.hdr.sgml : 20240502 20240502124513 ACCESSION NUMBER: 0001127602-24-013820 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240430 FILED AS OF DATE: 20240502 DATE AS OF CHANGE: 20240502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EISENBERG GLENN A CENTRAL INDEX KEY: 0001222831 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 24906700 MAIL ADDRESS: STREET 1: P O BOX 1017 CITY: CHARLOTTE STATE: NC ZIP: 28201-1017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 133757370 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-04-30 0000920148 LABORATORY CORP OF AMERICA HOLDINGS LH 0001222831 EISENBERG GLENN A 531 SOUTH SPRING STREET BURLINGTON NC 27215 1 Chief Financial Officer, EVP 0 Common Stock 2024-04-30 4 M 0 10229 A 50785 D Common Stock 2024-04-30 4 F 0 4496 201.37 D 46289 D Performance Share Unit 2024-04-30 4 M 0 10229 D 2024-05-10 Common Stock 10229 0 D Each Performance Share represents the contingent right to receive one share of Laboratory Corporation of America Holdings ("Labcorp") Common Stock. Stock withholding to satisfy tax withholding obligations. Amount includes an additional 1,059 Performance Shares resulting from the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea Holdings Inc. ("Fortrea"). The Performance Shares vested in full upon the filing of the Company's Quarterly Report on Form 10-Q for the first quarter of 2024, subject to both continued service and satisfaction of a performance condition related to the spin-off of Fortrea. /s/ Sandra D. van der Vaart, Attorney-in-Fact for Glenn A. Eisenberg 2024-05-02